SynchroPET Company
We build the smallest Positron Emission Tomography (PET) Scanners in medical imaging and research. Our first device promises to disrupt the nuclear imaging market by providing a non invasive input function that makes all PET scanners more quantitative and better at diagnosis and treatment of diseases like cancer, alzheimers, and parkinson's. This new quantitative data opens up and accelerates new possibilities in personalized medical treatments and cures.
Headquarters:
40.8005853
Industry:
Sensing/Imaging/Diagnostics
Super Industry:
Quantum Medicine
Funding Stage:
Early Stage Venture
Funding Total Value:
1475000
Founders:
Aaron McFarland,David Smith,Marc Alessi
Phone Number:
(631) 775-8909